Financing channel feed

The next-gen IL-2 race heats up as Anaveon se­cures a megaround with its sights set on mid-stage tests

4 years ago

Ital­ian can­cer gene ther­a­py biotech makes his­to­ry with mod­est Nas­daq IPO

4 years ago

Al­ice Zhang's 'all-in-hu­man' AI and ge­nomics up­start scores a $98M Se­ries B

4 years ago
AI

Rid­ing an ADC hot streak, a new biotech bets a megaround that a bet­ter ver­sion of those ther­a­pies is­n't a myth

4 years ago

BeiGene slides on Shang­hai de­but as US preps to black­list some Chi­nese biotechs

4 years ago

Lin­ing up a fil­ing for lead ROS1 in­hibitor, transpa­cif­ic on­col­o­gy biotech An­Heart Ther­a­peu­tics rais­es $61M

4 years ago
China

Qim­ing-backed CAN­bridge gets its Hong Kong IPO as Nas­daq slow­down prompts re­newed mar­ket analy­sis

4 years ago
China

The lat­est health­care SPAC comes in at $200M with a laser fo­cus on ar­ti­fi­cial in­tel­li­gence

4 years ago
AI

Dekkers-found­ed in­vest­ment firm No­valis Life­Sciences rais­es $300M for sec­ond fund and adds to the team

4 years ago

Eir Ven­tures tops up life sci­ences fund with $138M for Nordic biotechs

4 years ago

Fledg­ling Stan­ford spin­out promis­ing 3D mod­els of ful­ly hu­man tis­sue wins the back­ing of some big-time in­vestors

4 years ago
Cell/Gene Tx

Cin­gu­late prices a down­sized pub­lic of­fer­ing as IPO par­ty ap­pears to die down

4 years ago

At­las, F-Prime launch K36 Ther­a­peu­tics to ad­vance on­col­o­gy mol­e­cule for elu­sive epi­ge­net­ic tar­get

4 years ago
Startups

Ex-FDA chief Stephen Hahn lands an­oth­er new gig, this time as CEO of a can­cer test­ing start­up

4 years ago
FDA+

Mer­ck KGaA's ven­ture arm is ready to make new in­vest­ments, rais­ing more than $675M to get things go­ing

4 years ago
Pharma

Vi­vo Cap­i­tal, Bain, Pri­mav­era pour $200M in­to vir­tu­al­ly un­known tar­get­ed on­col­o­gy play out of Chi­na

4 years ago
China

New­path Part­ners kicks off $350M fund with a wun­derkind hold­ing the bag and an all-star sci­en­tif­ic team wait­ing in the wings

4 years ago
Startups

Lon­don AI-fo­cused Benev­o­len­tAI go­ing pub­lic in Eu­rope via $438M SPAC deal

4 years ago
AI

Can a new Eu­ro­pean biotech make an ADC bet­ter than Pad­cev? In­vestors are putting up al­most $100M to find out

4 years ago

Ice­landic bil­lionare's biosim­i­lar com­pa­ny rais­es $450M, preps for Nas­daq launch with SPAC merg­er

4 years ago
Startups

Al­ways busy, Gary Glick re­cruits Or­biMed in a mas­sive $218M Se­ries A for enig­mat­ic da­ta sci­ence biotech

4 years ago
People
Startups

Transpa­cif­ic AI biotech makes its Se­ries A de­but — putting $86M in the bank

4 years ago
Startups
AI

Ap­ple Tree Part­ners leaps across the pond to launch a UK biotech look­ing to crack the se­crets of den­drit­ic cells

4 years ago
Startups
Cell/Gene Tx

Even as boom wanes, a new $200M SPAC is still hop­ing for an­oth­er big score

4 years ago
First page Previous page 62636465666768 Next page Last page
A service from the Financial Times